Cancer Treatment Centers of America

Hematologic Oncology

Hematologic Oncology

“Our hematologic oncology program is committed to untangling the complexities of blood cancers and figuring out optimal treatment options. Seeing a specialist in blood cancers, specifically a hematologist or a hematologic oncologist, helps our patients get more detailed, specialized information that may empower them to make informed decisions about their diagnostic and treatment plans.”

-Dr. Brion Randolph, Medical Director of Hematologic Oncology

Our department

The Hematologic Oncology Department at Cancer Treatment Centers of America (CTCA) provides advanced medical therapies for patients with blood-related diseases, including leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and multiple myeloma.

Our hematologic oncology team has expertise in treating hematologic diseases using advanced technology and a personalized approach. We use state-of-the-art diagnostic tests to develop an individualized treatment plan that's tailored to your needs.

Helping you maintain your quality of life

Our hematology oncology team will work with the rest of your care team to support you throughout your treatment.

For example, your dietitian may recommend a healthy diet to nutritionally fortify your body, and your naturopathic clincian may recommend natural therapies to help reduce side effects, such as neuropathy. Your rehabilitation therapist may recommend safe levels of physical activity to help you stay active and independent.

Additionally, your pain management practitioner may use various techniques to help alleviate discomfort and control bone and neuropathic pain, while your mind-body therapist may provide counseling and relaxation techniques.

The hematologic oncology team at Southeastern

The doctors in the hematologic oncology program at Cancer Treatment Centers of America® (CTCA) at Southeastern Regional Medical Center (Southeastern) are dedicated to fighting the wide variety of blood cancers using advanced and innovative medical techniques. We offer an array of treatments, including autologous transplant services, for patients with newly diagnosed blood cancer and relapsed/refractory blood cancer.

At the same time, by addressing the side effects of cancer and its treatment with supportive care therapies, our care team strives to help patients reduce treatment interruptions and improve their quality of life. In addition to conventional treatment approaches, your care team may help you determine whether you qualify for one of our ongoing clinical trials, which may offer access to new, innovative treatments for your type of cancer.

From diagnostic testing to transplants and other treatments, all aspects of our comprehensive hematologic oncology program are delivered under one roof, so you don’t have to travel from location to location.

Our program is led by Drs. Brion Randolph, John Pawloski and Mary Ninan. A Medical Oncologist and Hematologist, Dr. Randolph is the Interim Chief of Medical Oncology and the Medical Director of Hematologic Oncology at Southeastern. His areas of expertise include multiple myeloma, stem cell transplants and clinical research. Prior to joining CTCA®, Dr. Randolph conducted research at the University of South Carolina Medical School, Baylor College of Medicine and Johns Hopkins Medical Institute in Baltimore, Maryland. He is currently the principal investigator for hematology clinical trials at Southeastern Regional Medical Center.

Dr. Pawloski joined CTCA in 2015 to assist in the establishment of the stem cell transplant and cellular therapy program at Southeastern Regional Medical Center.  Dr. Pawloski completed a joint Doctor of Medicine and Doctor of Philosophy (PhD) degree at St. Louis University School of Medicine before completing his training in Hematology at Duke University.  His areas of expertise include leukemia, myelodysplastic syndrome and stem cell transplants. Dr. Pawloski is an established researcher with studies and commentaries that have been published in many medical journals, including Nature, the Proceedings of the National Academy of Sciences, the New England Journal of Medicine and Transfusion.

Dr. Ninan is a Hematologic Oncologist who is board certified in internal medicine, hematology and medical oncology. Prior to joining CTCA, Dr. Ninan was a professor of hematology and oncology at the University of Texas Medical Branch in Galveston. Her areas of expertise include lymphoma and clinical research.

Stem cell transplantation

A stem cell transplant can be used to infuse healthy stem cells into the body to stimulate new bone marrow growth, suppress the disease and reduce the possibility of a relapse. Stem cells can be found in the bone marrow, circulating blood (peripheral blood stem cells) and umbilical cord blood.

For patients who need a stem cell transplant, our Stem Cell Unit includes an outpatient clinic, infusion center and inpatient rooms. When you first visit the hospital, you’ll meet with the hematologic oncology team. Your doctor will review your medical records and determine if you need additional diagnostic testing, such as lab work or imaging tests.

Once you’ve completed any necessary testing, your doctor will present you with treatment options, which may include autologous stem cell transplants.

The hematologic oncology team will care for you throughout your treatment. You’ll stay in one of our private, inpatient rooms and receive around-the-clock monitoring and care. We'll do everything possible to see that you and your family are comfortable throughout your stay.

Hospitals
HOSPITALS
Cancer Types
CANCER TYPE
Our Doctors
OUR DOCTORS
INSURANCE
INSURANCE